Skip to main content
. 2011 May 1;3(3):310–317. doi: 10.4161/mabs.3.3.15530

Table 4.

Selected therapeutic antibodies against new targets

Company Drug name Target Key patent
Ganymed GT468 Placental protein PLAC1 EP2166021
Merrimack MM-111 Human epidermal growth factor receptor (HER)2 + HER3 US7332580
LPath Sphingomab Sphingosine-1-phosphate US7829674